XTalks

JULY 24, 2024

The National Institutes of Health (NIH) developed an AI tool called Logistic Regression-Based Immunotherapy-Response Score (LORIS) to predict how cancer patients will respond to immune checkpoint inhibitors. This data provides valuable insights into the effectiveness of therapies in real-world settings. Nanostics Inc.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

Delveinsight

FEBRUARY 17, 2021

Almost all the aspects of the healthcare sector, such as service delivery, communications, operation, medical equipment, and drug development, have grown remarkably and improved the overall health outcome. Improvement in the diagnostics, management of chronic conditions, drug and device development, are some of the key applications of AI.

Doctor 52

Doctor Doctors Big Data Development 52

Pharma Marketing Network

OCTOBER 14, 2024

The rise of big data analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing. With advancements in genomics and biotechnology, there is a move towards tailoring treatments to individual patients based on their genetic makeup.

Marketing 52

Marketing Branding Big Data Drugs 52

The Pharma Data

JANUARY 4, 2021

Kiromic’s deep understanding of the tumor micro environment (TME) and the tumors’ escape and masking mechanisms led to development of a promising platform for chimeric antigen receptor therapy (CAR-T). PD-1 has always been a challenge for CAR-T development. “We believe Prof. About PD-1 Check-point inhibition.

In-Vivo 40

In-Vivo Development Immune Response Big Data 40

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Data privacy and protection, patient voice.

Genome 105

Genome Genomics Research Medicine 105

pharmaphorum

SEPTEMBER 18, 2020

The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin. “AstraZeneca will have a strong base for considerable expansion, especially in research and development and geographical presence. Zeneca Group plc. MedImmune acquisition.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

APRIL 8, 2022

Dennis Kadioglu is the deputy head of both the Medical Informatics Group (MIG) and the Data Integration Center (DIC) at the University Hospital Frankfurt in Frankfurt am Main. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .

Genome 78

Genome Genomics Research Big Data 78

pharmaphorum

MARCH 16, 2021

The use of real-world evidence is proving beneficial for pharma and medical devices companies across the lifecycle of development from R&D to re-purposing. Savana is unique as an EHR reuse provider and we have a community of doctors using this system in 14 countries in five languages.”. About Savana.

Doctors 116

Doctors Doctor Life Science Clinical Research 116

pharmaphorum

FEBRUARY 17, 2022

Identified as the “VB variant,” the virus has proved to be highly virulent and to speed up the progression of a patient developing AIDS faster. Led by researchers from the University of Oxford ‘s Big Data Institute, the study underscores the significance of analysing viruses continually over time.

Genome 98

Genome Genomics Genetics Genotype 98

The Pharma Data

JANUARY 17, 2021

There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. Syntegra has also engaged with the Federal Drug Administration (FDA) to evaluate the role of synthetic data in regulatory decisions, for COVID-19 and beyond.

Life Science 52

Life Science Engineer Big Data Scientist 52